 CINCINNATI, Oct. 14, 2021 PRNewswire -- Meridian Bioscience, Inc. NASDAQ: VIVO, a leading global provider of diagnostic testing solutions and life science raw materials, will report fourth quarter and full year 2021 financial results Friday, November 12, 2021. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. 